ArticleBMC pediatrics2026
Association of 25(OH)D with general and abdominal obesity among children and adolescents in the United States: a cross-sectional NHANES analysis.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectiveThis study aims to investigate the relationship between serum 25-hydroxyvitamin D (25(OH)D) levels and the prevalence of obesity and abdominal obesity among children and adolescents, utilizing data from the National Health and Nutrition Examination Survey (NHANES). MATERIALS AND
methodsData were extracted from the NHANES conducted between 2009 and 2018. This study included a total of 7,451 children and adolescents aged 8 to 17 years. The statistical analyses employed in this research comprised descriptive statistics, weighted linear regression, multivariate logistic regression, and restricted cubic spline analysis.
resultsSignificant differences in baseline characteristics were observed across the quartiles of serum 25(OH)D levels. Higher levels of 25(OH)D were associated with a greater proportion of males, younger age groups (8-12 years), non-Hispanic whites, and non-poor. Logistic regression analysis indicated that individuals in the lowest quartile of 25(OH)D levels faced a higher odd of obesity (OR: 2.82, 95% CI: 2.08-3.83) and abdominal obesity (OR: 2.42, 95% CI: 1.97-2.98) after adjusting for covariates. Restricted cubic spline analysis showed a nonlinear association between serum 25(OH)D and obesity prevalence, with an inflection point near 56.51 nmol/L; this observation does not imply causality or directionality.
conclusionLower serum levels of 25(OH)D are correlated with a higher prevalence of obesity and abdominal obesity among children and adolescents. These findings underscore the need for longitudinal or intervention studies to determine whether maintaining adequate 25(OH)D levels can help lower obesity risk in this demographic.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.